Silence Therapeutics plc APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Silence Therapeutics plc (SLN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-10
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.31M, a 37.27% decline year-over-year.
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.45M, a 30.88% decline year-over-year.
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.54M, a 37.67% decline year-over-year.
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $2.08M, a 49.65% decline year-over-year.
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $8.07M, a 50.49% decline from fiscal 2024.
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $16.31M, a 0.20% increase from fiscal 2023.
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $16.27M, a 28.28% increase from fiscal 2022.
- Silence Therapeutics plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $12.69M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.31M 10-Q · filed 2026-08-10 | $3.75M derived: sum of 2 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $2.45M 10-Q · filed 2026-08-10 | |||
| 2025-12-31 | $8.07M 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $2.54M 10-Q · filed 2025-11-06 | $4.62M derived: sum of 2 quarters · filed 2026-08-10 | $8.16M derived: sum of 3 quarters · filed 2026-08-10 | |
| 2025-06-30 | $2.08M 10-Q · filed 2026-08-10 | $5.63M derived: sum of 2 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $3.54M 10-Q · filed 2026-08-10 | |||
| 2024-12-31 | $16.31M 10-K · filed 2026-03-05 | |||
| 2024-09-30 | $4.07M 10-Q · filed 2025-11-06 | $8.21M derived: sum of 2 quarters · filed 2025-11-06 | $12.33M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $4.14M 10-Q · filed 2025-11-06 | $8.26M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $4.12M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $16.27M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $12.69M 10-K · filed 2025-02-27 |